Design Cloud

Image Name

News

Home page

Party group dynamics

Employee activity

Public Notice of the Environmental Impact Assessment for the R&D Center Incubator Workshop Project of Wanbangde Pharmaceutical Group Co., Ltd.

Date:

01 Mar,2021

The full text is attached. Click to download

Previous page

Wanbangde Pharmaceutical GMP Knowledge Competition Concludes

Wanbangde Pharmaceutical Group Co., Ltd. Announces Public Disclosure of the Environmental Impact Assessment for Its New Technical Renovation Project, which will add annual production capacity for 20 tons of Bifendate API, 980 tons of Norfloxacin API, and 10 tons of Traditional Chinese Medicine Extracts.

Next page

Related Recommendations

Image Name

2025/04/14

Mingjie Pharma's inaugural national CMC pharmacy salon tour for 2025 concludes successfully | Wanbangde Pharmaceutical deeply engages in technical exchanges

Image Name

2025/04/14

Good News | Maband Pharmaceutical Group's Mecobalamin Granted Orphan Drug Designation by the U.S. FDA for the Treatment of ALS

Image Name

2025/04/14

[Another Milestone: Wanbangde Pharmaceutical Group's Huperzine A Injection Included in the "Clinical Guidelines for Rational Drug Use in Cerebrovascular Diseases"]

< 1 2 3 4...78 > proceed page

Image Name

Website Development: China Enterprise Dynamics Taizhou

Business license

浙ICP备10002622号-38